MMAI
id:
mmai-181-16869378
title:
MMAI
text:
5-Methoxy-6-methyl-2-aminoindane (MMAI) is a drug developed in the 1990s by a team led by David E. Nichols at Purdue University. It acts as a non-neurotoxic and highly selective serotonin releasing agent (SSRA) and produces entactogen effects in humans. It has been sold as a designer drug and research chemical online since 2010. MMAI has been shown to relieve stress-induced depression in rats more robustly than sertraline, and as a result it has been suggested that SSRAs like MMAI and 4-MTA coul
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/MMAI
date created:
2009-04-30T06:28:59Z
date modified:
2024-09-06T01:38:18Z
main entity:
{"identifier":"Q15409380","url":"https://www.wikidata.org/entity/Q15409380"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/4/47/5-methoxy-6-methyl-2-aminoindane.svg","width":311,"height":160}
fields total:
13
integrity:
16